TipRanks
Dongguang Chemical Ltd. (HK:1702)
:1702
Hong Kong Market
Want to see HK:1702 full AI Analyst Report?

Dongguang Chemical Ltd. (1702) AI Stock Analysis

0 Followers

Top Page

HK:1702

Dongguang Chemical Ltd.

(1702)

Select Model
Select Model
Select Model
Outperform 70 (OpenAI - Gpt-5.6Sol)
Rating:70Outperform
Price Target:
HK$2.00
▲(6.38% Upside)
Action:Reiterated
Date:10/08/26
The score is led by strong balance-sheet quality and an inexpensive valuation (low P/E with a dividend), offset by weak multi-year revenue trends and recent negative free cash flow. Technicals are supportive but somewhat overheated due to an overbought RSI.
Positive Factors
Conservative balance sheet
Very low leverage and a growing equity base provide a substantial financial cushion. This conservative funding structure limits balance-sheet risk, reduces sensitivity to financing costs, and preserves flexibility to manage operating volatility over the next several quarters.
Negative Factors
Multi-year revenue contraction
A prolonged decline in revenue signals weakening top-line momentum and makes future profit growth harder to sustain. The sharp latest-period contraction also raises the risk that the 2025 earnings recovery may not translate into durable expansion without renewed business growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Very low leverage and a growing equity base provide a substantial financial cushion. This conservative funding structure limits balance-sheet risk, reduces sensitivity to financing costs, and preserves flexibility to manage operating volatility over the next several quarters.
Read all positive factors

Dongguang Chemical Ltd. (1702) vs. iShares MSCI Hong Kong ETF (EWH)

Dongguang Chemical Ltd. Business Overview & Revenue Model

Company Description
Dongguang Chemical Limited, an investment holding company, manufactures and sells urea primarily in the People’s Republic of China. The company offers coal-based urea for use as a source of nitrogen in fertilizers and industrial applications, such...

Dongguang Chemical Ltd. Financial Statement Overview

Summary
Financials are mixed: a strong, low-leverage balance sheet (very low debt-to-equity and growing equity) supports stability, but operating performance is pressured by a multi-year revenue contraction and margin volatility. Cash flow quality improved in 2025 (operating cash flow exceeded net income), yet free cash flow has been negative in 2024–2025, limiting overall strength.
Income Statement
62
Positive
Balance Sheet
86
Very Positive
Cash Flow
55
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.41B2.38B2.58B2.92B3.13B2.88B
Gross Profit226.66M199.83M172.05M332.96M329.61M458.81M
EBITDA307.47M273.39M260.67M406.97M412.42M564.65M
Net Income179.92M140.02M84.61M190.08M194.38M266.08M
Balance Sheet
Total Assets2.51B2.22B2.02B2.10B1.87B1.84B
Cash, Cash Equivalents and Short-Term Investments755.05M679.07M702.10M797.81M535.47M425.06M
Total Debt49.39M73.67M28.14M28.04M28.36M124.29M
Total Liabilities501.75M283.62M211.98M334.04M248.69M361.52M
Stockholders Equity1.99B1.92B1.80B1.76B1.61B1.47B
Cash Flow
Free Cash Flow-49.95M-23.34M-68.89M302.42M261.12M271.56M
Operating Cash Flow390.22M299.47M119.76M372.77M306.18M350.37M
Investing Cash Flow-400.27M-319.66M-171.00M-62.89M-36.38M-48.25M
Financing Cash Flow-14.53M-20.36M-50.99M-53.16M-159.45M-238.97M

Dongguang Chemical Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1.88
Price Trends
50DMA
1.63
Positive
100DMA
1.63
Positive
200DMA
1.69
Positive
Market Momentum
MACD
0.04
Negative
RSI
77.86
Negative
STOCH
64.38
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1702, the sentiment is Positive. The current price of 1.88 is above the 20-day moving average (MA) of 1.74, above the 50-day MA of 1.63, and above the 200-day MA of 1.69, indicating a bullish trend. The MACD of 0.04 indicates Negative momentum. The RSI at 77.86 is Negative, neither overbought nor oversold. The STOCH value of 64.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1702.

Dongguang Chemical Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
HK$1.07B5.719.19%2.06%3.26%181.56%
70
Outperform
HK$18.56B8.7012.67%2.68%7.79%48.48%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
HK$4.23B4.8413.63%4.05%0.90%16.54%
59
Neutral
HK$900.38M15.382.08%2.91%16.60%-12.13%
50
Neutral
HK$11.37B-16.93-18.41%0.83%165.47%-398.61%
42
Neutral
HK$274.09M-0.30214.56%―1.56%-21.85%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1702
Dongguang Chemical Ltd.
1.94
0.28
17.15%
HK:0827
Ko Yo Chemical (Group) Limited
0.04
<0.01
31.03%
HK:0609
Tiande Chemical Holdings Limited
1.03
-0.43
-29.36%
HK:0189
Dongyue Group Limited
11.20
-1.26
-10.13%
HK:2198
China Sanjiang Fine Chemicals Co., Ltd.
3.70
0.74
25.00%
HK:6616
Global New Material International Holdings Limited
9.32
4.71
102.17%

Dongguang Chemical Ltd. Corporate Events

Dongguang Chemical Delivers Strong Profit Growth in First-Half 2026 Results
Aug 27, 2026
Dongguang Chemical Limited reported unaudited interim revenue of RMB1,210.3 million for the six months ended 30 June 2026, up slightly from RMB1,180.8 million a year earlier, reflecting modest top-line growth in its chemical product business. The ...
Dongguang Chemical Flags 55% Interim Profit Surge on Revenue Growth and Urea Hedging Gains
Aug 19, 2026
Dongguang Chemical Limited has issued a positive profit alert, indicating that the group expects net profit for the six months ended 30 June 2026 to rise by about 55% compared with the same period in 2025. The improvement is attributed to higher r...
Dongguang Chemical Sets August Board Meeting to Review Interim Results and Dividend
Aug 17, 2026
Dongguang Chemical Limited has scheduled a board meeting for 27 August 2026 to review and approve its unaudited consolidated financial statements for the six months ended 30 June 2026. The board will also consider the declaration of an interim div...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 08, 2026